<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><description>为您传递细胞治疗相关行业信息与技术进展，共同促进国内免疫治疗技术发展与行业繁荣。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 27 Apr 2021 19:19:04 +0800</pubDate><image><url>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</url><title>CytoCares | wechat-feeds</title><link>http://MzAxNjQ3NjI4MA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Trop-2 ADC风起云涌：复旦张江加入战场，第一三共/阿斯利康再度携手</title><link>https://mp.weixin.qq.com/s/3_q6u-hL3Mx8lWWhacp78A</link><description></description><content:encoded><![CDATA[Trop-2 ADC风起云涌：复旦张江加入战场，第一三共/阿斯利康再度携手]]></content:encoded><pubDate>Tue, 27 Apr 2021 18:05:48 +0800</pubDate></item><item><title>自免明星靶点IL-17：从发现到靶向治疗</title><link>https://mp.weixin.qq.com/s/Yu251aoughYnX5JvpIVPFg</link><description></description><content:encoded><![CDATA[自免明星靶点IL-17：从发现到靶向治疗]]></content:encoded><pubDate>Mon, 26 Apr 2021 18:28:34 +0800</pubDate></item><item><title>抗体药物动态-20210426</title><link>https://mp.weixin.qq.com/s/1xntPguEXgorXb7wW6noTg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210426]]></content:encoded><pubDate>Mon, 26 Apr 2021 18:28:34 +0800</pubDate></item><item><title>mRNA药物时代，不仅仅有疫苗</title><link>https://mp.weixin.qq.com/s/nPn46mzwAEcSFoRXP8qp3Q</link><description></description><content:encoded><![CDATA[mRNA药物时代，不仅仅有疫苗]]></content:encoded><pubDate>Sun, 25 Apr 2021 17:56:11 +0800</pubDate></item><item><title>ADC蓄势待发：11种上市产品和在研新药将争夺百亿美元市场</title><link>https://mp.weixin.qq.com/s/OzEsaBq4c4Qz3JSSIK2paQ</link><description></description><content:encoded><![CDATA[ADC蓄势待发：11种上市产品和在研新药将争夺百亿美元市场]]></content:encoded><pubDate>Fri, 23 Apr 2021 19:13:17 +0800</pubDate></item><item><title>抗体药物动态-20210423</title><link>https://mp.weixin.qq.com/s/RPze4FFsLjFWmxNP-qM9sA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210423]]></content:encoded><pubDate>Fri, 23 Apr 2021 19:13:17 +0800</pubDate></item><item><title>抗体药物动态-20210422</title><link>https://mp.weixin.qq.com/s/uurFfcrNa_VL1vKWhxbL1A</link><description></description><content:encoded><![CDATA[抗体药物动态-20210422]]></content:encoded><pubDate>Thu, 22 Apr 2021 18:22:35 +0800</pubDate></item><item><title>肿瘤CD8+T细胞功能障碍--驱动因素、调控、标志物、修复</title><link>https://mp.weixin.qq.com/s/WexqzSmAUWZY4NJqt12vvg</link><description></description><content:encoded><![CDATA[肿瘤CD8+T细胞功能障碍--驱动因素、调控、标志物、修复]]></content:encoded><pubDate>Wed, 21 Apr 2021 18:50:09 +0800</pubDate></item><item><title>抗体药物动态-20210421</title><link>https://mp.weixin.qq.com/s/onGGTZ2SW1slbrjArNwHsA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210421]]></content:encoded><pubDate>Wed, 21 Apr 2021 18:50:09 +0800</pubDate></item><item><title>抗体药物动态-20210420</title><link>https://mp.weixin.qq.com/s/qbT69kwTXrlWE3hyFd-aCg</link><description></description><content:encoded><![CDATA[抗体药物动态-20210420]]></content:encoded><pubDate>Tue, 20 Apr 2021 18:44:56 +0800</pubDate></item><item><title>自身过敏：IgE介导，兼具自免和过敏特点</title><link>https://mp.weixin.qq.com/s/XN8ibLO5fn_RHRz8Zq12yA</link><description></description><content:encoded><![CDATA[自身过敏：IgE介导，兼具自免和过敏特点]]></content:encoded><pubDate>Mon, 19 Apr 2021 18:08:12 +0800</pubDate></item><item><title>双特异性抗体：on-target off-tumor毒性及克服策略</title><link>https://mp.weixin.qq.com/s/rfjJyKwyAzjLKggrsof_NQ</link><description></description><content:encoded><![CDATA[双特异性抗体：on-target off-tumor毒性及克服策略]]></content:encoded><pubDate>Fri, 16 Apr 2021 18:10:21 +0800</pubDate></item><item><title>抗体药物动态-20210416</title><link>https://mp.weixin.qq.com/s/yRFVHPDjzdOXp6v1KakixA</link><description></description><content:encoded><![CDATA[抗体药物动态-20210416]]></content:encoded><pubDate>Fri, 16 Apr 2021 18:10:21 +0800</pubDate></item><item><title>2021AACR年会：聚焦四大新型免疫疗法！CAR-T、TILs、癌症疫苗、溶瘤病毒大放异彩！</title><link>https://mp.weixin.qq.com/s/tQMmpoQtHfXXr49lTndJhg</link><description></description><content:encoded><![CDATA[2021AACR年会：聚焦四大新型免疫疗法！CAR-T、TILs、癌症疫苗、溶瘤病毒大放异彩！]]></content:encoded><pubDate>Thu, 15 Apr 2021 18:42:29 +0800</pubDate></item></channel></rss>